Product News

Share this article:

AstraZeneca's Seroquel XR picked up an indication for the treatment of acute depressive, manic, and mixed episodes of bipolar disorder. The drug is now available in two new tablet strengths: 50 mg and 150 mg.

Takeda's proton pump inhibitor Kapidex received FDA approval for the treatment of heartburn associated with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE. It is now available in US pharmacies in 30mg and 60mg doses.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.